# Aquapharm Biodiscovery

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aquapharm-biodiscovery

- Industry: Pharmaceuticals
- Headquarters: UK
- Website: http://www.aquapharm.co.uk
- Total disclosed funding: $16M
- Latest round: Series A (Mar 19, 2010)
- Investors on record: 6

## About

Aquapharm Biodiscovery is focused on the development of pharmaceuticals and functional ingredients derived from marine microbes, utilizing innovative biotechnological solutions for various health-related applications.Founded in 2000 in the UK, Aquapharm Biodiscovery specializes in marine-derived pharmaceuticals. The company has undergone strategic changes, recently acquired by Lallemand in December 2013. Its founder has not been publicly detailed, nor are there known subsidiaries. Aquapharm has engaged in 4 deals, with the latest funding round being a Series A amounting to GBP 4.160 mn, raising a total of GBP 4.160 mn and valuing the company at GBP 11.413 mn.Aquapharm Bio-Discovery develops pharmaceuticals and functional ingredients from marine microbes. Their offerings include potential antibiotics, anti-inflammatory agents, and anti-cancer drugs. They also produce nutraceuticals such as vitamins and antioxidants, alongside industrial compounds. These products serve the pharmaceutical, nutraceutical, and personal care markets in Europe, North America, and Asia.In its most recent fiscal year of 2013, Aquapharm Biodiscovery reported a revenue of GBP 337,082 and an EBITDA of GBP -2,701,891.9, reflecting the operational dynamics of the company during that period.Aquapharm Biodiscovery aims to expand its product line, with new pharmaceuticals in development focusing on marine biochemistry. The company plans to enter additional markets in Europe and North America by 2015. Recent funding from the Series A round will be utilized to support these new product initiatives and market expansions.

## Funding rounds

- Series A, Mar 19, 2010, $6.2M — Tate & Lyle Ventures, Aescap Venture, NESTA Investments, Highlands and Islands Enterprise
- Series A, Jul 23, 2007, $8M — Tate & Lyle Ventures, Aescap Venture, NESTA Investments, Highlands and Islands Enterprise, Scottish Enterprise
- Series A, Oct 14, 2004, $1.7M — E-Synergy, NESTA Investments, Scottish Enterprise

## Investors

- E-Synergy (https://capitalatlas.ai/funds/e-synergy) — Series A
- NESTA Investments — Series A
- Scottish Enterprise (https://capitalatlas.ai/funds/scottish-enterprise) — Series A
- Tate & Lyle Ventures (https://capitalatlas.ai/funds/tate-lyle-ventures) — Series A
- Aescap Venture (https://capitalatlas.ai/funds/aescap-venture) — Series A
- Highlands and Islands Enterprise — Series A